During the past decade, Whan In Pharm. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Whan In Pharm." are "Schizophrenia" (2 trials) and "Partial-onset Seizures With or Without Secondary Generalisation" (1 trials). Many other conditions were trialed in "Whan In Pharm." in a lesser frequency.

Most popular intervention types in "Whan In Pharm." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Clozaril 100 mg (Clozapine)" (1 trials), "Placebo for WID-RGC20(Cariprazine) 3mg/day or 6mg/day" (1 trials), "Placebo for Zebinix 1600mg" (1 trials), "Placebo for Zebinix 400mg" (1 trials) and "Placebo for Zebinix 800mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Whan In Pharm." are 3 trials for "All" genders.

Currently, there are NaN active trials in "Whan In Pharm.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Whan In Pharm., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Whan In Pharm., 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".